An interventional study of Reduction mammaplasty in To Compare Complications of Both Techniques in Wise Pattern Reduction Mammaplasty and to Correlate Between Complications and Patient Mediated Factors, sponsored by Kafrelsheikh University. Status unknown at 1 site in Egypt. Open to female participants. Per ClinicalTrials.gov, last updated 2020-11-27.
Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment
A comparison study between superomedial and Inferior pedicle techniques in wise pattern reduction mammaplasty
To compare complications of both techniques in wise pattern reduction mammaplasty and to correlate between complications and patient mediated factors
Kafrelsheikh University is the lead sponsor of 285 studies on the registry; 110 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
-
Exclusion Criteria:
Wise pattern reduction mammaplasty using Inferior pedicle
Procedure: Reduction mammaplasty
Procedure: Reduction mammaplasty
Breast reduction surgery
Also known as: Superomedial pedicle versus Inferior pedicle techniques in wise pattern reduction mammaplasty
To compare complications of both techniques including nipple areola complex necrosis
Complications include NAC necrosis and other minor complications including wound dehiscence and seroma or hematoma
Time frame: 30 days postoperative
To correlate between complications and patient mediated factors
Patient mediated factors including age, BMI, preoperative hb, suprasternal notch to nipple distance
Time frame: 30 days postoperative
Plan to share: Yes
Supporting information: Study protocol, Sap
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kafrelsheikh University